Author： Rubins J.B.
Publisher： Adis International
ISSN： 1170-229X
Source： Drugs & Aging, Vol.18, Iss.5, 2001-01, pp. : 305-311
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Advances in Pneumococcal Vaccines: What are the Advantages for the Elderly?
Drugs & Aging, Vol. 24, Iss. 10, 2007-01 ,pp. :
Access to resources
Recommend
What's the real cost of preventing chronic disease in the US?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 572, 2009-01 ,pp. :
Pneumococcal vaccine: suboptimal efficacy in the elderly
Inpharma, Vol. 1, Iss. 1293, 2001-01 ,pp. :
Is the evidence recommending pneumococcal vaccine valid?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 376, 2002-01 ,pp. :
Is the evidence recommending pneumococcal vaccine valid?
Inpharma, Vol. 1, Iss. 1351, 2002-01 ,pp. :